Disaster Management Act, 2002 (Act No. 57 of 2002)

Notices

Directions on the establishment of a COVID-19 Vaccine Injury No-Fault Compensation Scheme issued in terms of the Act

Schedules

Schedule 1 : Applicable Vaccines
Purchase cart Previous page Return to chapter overview Next page

 

The following vaccines approved for use by the South African Health Products Regulatory Authority  (SAHPRA):

 

1.Comirnaty and Pfizer-BioNTech COVID-19 Vaccine

 

2.Johnson & Johnson's Janssen COVID-19 Vaccine, Name: JNJ-78436735,

Manufacturer: Janssen Pharmaceuticals Companies of Johnson & Johnson,

 

that were donated to the National Department of Health, obtained by the Government of South Africa in terms of the CoVAX facility, or which were procured by the Government of the Republic of South Africa acting through the National Department of Health in terms of the following agreements:

 

1.with Pfizer Laboratories Proprietary Limed dated 26 March 2021 and 04 April 2021;

 

2.with Janssen Pharmaceutica NV dated dated 16 February and 18 April 2021.